Browsing: Next

Not long ago, ‘women’s health’ was treated as a single category within the supplement space, with menopause often viewed primarily through the lens of hot flashes. Today, that perspective has broadened to recognise that a women’s health extends far beyond a single life stage or symptom, and that every hormonal transition brings evolving needs that…

Eli Lilly (NYSE: LLY) is already the leader in the weight-loss market thanks to Zepbound, the best-selling medication in this space. However, the drugmaker has been making headlines with its next-gen anti-obesity medicine, retatrutide. Eli Lilly recently announced that it will request approval from the U.S. Food and Drug Administration for retatrutide in the first…

You love the idea of GLP-1s like Ozempic—getting to accomplish your weight-loss goals and reap surprising bonus benefits you’ve heard about, like a lower Alzheimer’s disease risk and less sleep apnea.—all with a weekly injection or a quick daily pill. But if the potential side effects have been holding you back, we’ve got good news.…

The past few years have been rough on Pfizer (NYSE: PFE). The company has generally posted subpar financial results due to weakness within its coronavirus franchise, which once helped it become the first biopharmaceutical company to achieve $100 billion in annual sales. The drugmaker is looking to turn things around by developing potential blockbuster products,…

As Appalachia continues to face disproportionately high rates of substance use disorder and opioid overdose, East Tennessee State University is helping prepare the next generation of researchers to address one of the region’s most pressing public health challenges

As healthcare leaders think about the future of their organizations, they must remember that despite the seemingly nonstop attention lavished on technology today what’s down the road will be determined by much more. It will depend on health systems using new tools and care models to make care more accessible, affordable and preventative

The COVID-19 pandemic marked a turning point for drug repurposing, bringing an approach that had long occupied a drug discovery niche into the global spotlight. The urgent need for effective therapies against an emerging viral threat drove a surge in funding, research, and development efforts, with support from regulators to identify new therapeutic uses for…

Key Takeaways: Results from a July 2026 study published in Frontiers in Psychologysuggest that what you smell prior to working out may have a positive impact on performance. Participants who smelled dark chocolate before strength training completed 18 more reps than those who smelled distilled water. Though the study is small, it provides meaningful insight regarding…

A Freezable Lunch Box, $20 Earbuds and More Back-to-School Essentials Fuel Up for Your Next Workout With These Nutrition Tips July 24, 202605:21 UP NEXT Things Drivers Do That Are More Likely to Get Them a Traffic Ticket 05:05 Why Bear Encounters Are Soaring Across the US 02:10 Exclusive: Purdue Set to Launch Amelia Earhart…

Investing.com — Eli Lilly announced Thursday it will file for approval of its next-generation obesity drug retatrutide in the first quarter of 2027, pushing back from an earlier timeline that targeted this year. The pharmaceutical company said it needs additional time to collect and verify manufacturing and quality-control data required by regulators